Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Leveraging Patient Advocacy To Scale Rare Disease Trials How To Prevent Failure in Rare Disease Trials? Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Solutions for Trial Design Challenges in Rare Disease Trials Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like Leveraging Patient Advocacy To Scale Rare Disease Trials How To Prevent Failure in Rare Disease Trials? Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Solutions for Trial Design Challenges in Rare Disease Trials Ethics and Strategies for Returning Individual Patient Data Collected in Clinical Research
